Literature DB >> 22551295

History and future of the European Board of Ophthalmology Diploma examination.

Danny G P Mathysen1, Wagih Aclimandos, Ella Roelant, Kristien Wouters, Catherine Creuzot-Garcher, Peter J Ringens, Marko Hawlina, Marie-José Tassignon.   

Abstract

PURPOSE: The European Board of Ophthalmology Diploma (EBOD) examination has evolved over the last few years, especially with the introduction of negative marking (-0.5 points) for incorrect or blank answers (0 points for don't know option), which aimed to improve the quality and reliability of the examination.
METHODS: In 2010, negative marking at the written part of the EBOD examination has been introduced in an attempt to improve not only the reliability of the examination as entity but also the statistical performance parameters of the individual questions. As lower pass rates and discrimination of female candidates are feared by the general public when negative marking is concerned, these parameters have been explicitly investigated.
RESULTS: Introduction of negative marking has not only lead to improved reliability of the EBOD examination (increased Cronbach's alpha value: ≤0.80 without and ≥0.90 with negative marking), but also to improved statistical performance parameters of the individual questions. The pass rate of the EBOD examination has proven to remain at the same high level as without negative marking (around 90%). Furthermore, although female candidates do seem to have different answering strategies (p < 0.01, use of don't know option), no statistically significant difference has been found between total scores of male and female candidates (p > 0.05).
CONCLUSION: Introduction of negative marking at the written EBOD examination has proven to be beneficial, not only for the organizers (improvement of the statistical performance of the examination and its questions), but also for candidates (better discrimination with borderline candidates). These results have been obtained without evidence of lower pass rates or discrimination of female candidates.
© 2012 The Authors. Acta Ophthalmologica © 2012 Acta Ophthalmologica Scandinavica Foundation.

Entities:  

Keywords:  clinical validation of test items; mathematical validation of test items; multiple-choice questions; statistical performance analysis

Mesh:

Year:  2012        PMID: 22551295     DOI: 10.1111/j.1755-3768.2012.02422.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  4 in total

1.  A large survey among European trainees in clinical microbiology and infectious disease on training systems and training adequacy: identifying the gaps and suggesting improvements.

Authors:  E Yusuf; D S Y Ong; A Martin-Quiros; C Skevaki; J Cortez; K Dedić; A E Maraolo; D Dušek; P J Maver; M Sanguinetti; E Tacconelli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-04       Impact factor: 3.267

2.  Can 'Fellow of the European Board of Ophthalmology Subspecialty Diploma in Glaucoma,' a subspecialty examination on glaucoma induce the qualification standard of glaucoma clinical practice in Europe?

Authors:  Gordana Sunaric-Mégevand; Wagih Aclimandos; Catherine Creuzot-Garcher; Carlo-Enrico Traverso; Anja Tuulonen; Roger Hitchings; Danny G P Mathysen
Journal:  J Educ Eval Health Prof       Date:  2016-07-28

Review 3.  Procedural aspects of the organization of the comprehensive European Board of Ophthalmology Diploma examination.

Authors:  Danny G P Mathysen; Peter J Ringens; Edoardo Midena; Artur Klett; Gordana Sunaric-Mégevand; Rafael Martinez-Costa; Denise Curtin; Marie-José Tassignon; Wagih Aclimandos; Catherine Creuzot-Garcher; Christina Grupcheva
Journal:  J Educ Eval Health Prof       Date:  2016-07-26

4.  Ophthalmology Training in Greece as Perceived by Resident Ophthalmologists in the Times of Crisis: A National, Questionnaire-based Survey.

Authors:  Lampros Lamprogiannis; Argyrios Tzamalis; Konstantinos T Tsaousis; Nikolaos Ziakas; Chrysanthos Symeonidis; Athanasios Karamitsos; Stavros Dimitrakos; Ioannis Tsinopoulos
Journal:  J Curr Ophthalmol       Date:  2020-03-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.